Home Blog Page 1173

NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization

By
Advertorial Desk
-

SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ — NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Nexsphere-F™, the company’s novel fast resorbable microsphere for musculoskeletal pain embolization has received approval from Health Canada.

Nexsphere-F™ is a fast resorbable microsphere designed for musculoskeletal pain embolization. It temporarily occludes abnormal blood vessels associated with osteoarthritis-related pain using resorbable microspheres, inducing necrosis of pain-generating nerve cells within 2 to 8 hours after the procedure and effectively reducing pain. Unlike permanent microspheres, Nexsphere-F™ is designed to naturally dissolve after embolization, significantly lowering the risk of post-procedural complications and supporting the growing clinical demand for osteoarthritis pain embolization.

In addition to Canadian approval, Nexsphere-F™ is currently the only resorbable embolic microsphere certified under CE-MDD for osteoarthritis pain embolization, and is commercialized in major European countries. At CIRSE 2025, the annual congress of the Cardiovascular and Interventional Radiological Society of Europe, Dr. Florian Nima Fleckenstein (Charité-Universitätsmedizin Berlin, Berlin, Germany) presented, “Using rapidly resorbable, gelatin-based microspheres(Nexsphere-F™) for knee osteoarthritis pain embolization resulted in significant improvements in pain and function, while demonstrating favorable safety compared to permanent microspheres or antibiotic-based compounds.” These findings were recently reported by Interventional News, a leading interventional radiology news.

Furthermore, a study published in Orthopaedic Journal of Sports Medicine (OJSM) highlighted the clinical efficacy and safety of Nexsphere-F™ for patients with patellar tendinopathy, a condition frequently seen in athletes. Additional clinical studies have reported its application in a wide range of musculoskeletal pain, including knee osteoarthritis, medial epicondylitis, plantar fasciitis.

The company is conducting multiple post-market clinical trials across several countries to further evaluate the efficacy and safety of Nexsphere-F™ for various indications, including osteoarthritis, patellar tendinopathy, elbow, wrist, plantar fasciitis, and other musculoskeletal conditions.

Nexsphere-F™ previously received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) and subsequently initiated a pivotal clinical trial for FDA approval, which is moving forward as planned. The study, named RESORB (Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain), is a multicenter, randomized controlled trial involving 126 patients with knee osteoarthritis across more than 10 U.S. clinical sites. The trial aims to evaluate the safety and efficacy of genicular artery embolization (GAE) with Nexsphere-F™ compared to intra-articular corticosteroid injections, with patient enrollment targeted to be completed within the first half of this year.

The company is currently in discussions with leading global partners regarding global distribution rights and is focusing its resources on accelerating the ongoing U.S. regulatory clinical trial to support successful entry into the North American market.

Now Available: JSAUX Split EveryDay Case for Switch 2

By
Advertorial Desk
-

Designed for daily convenience, the new series offers three modular configurations to match any lifestyle.

HONG KONG, Jan. 29, 2026 /PRNewswire/ — JSAUX, a leading gaming hardware brand, today announced the official launch of the Split EveryDay Case for Nintendo Switch 2. Designed to strike the perfect balance between portability and reliable protection, this new lineup provides a lightweight solution that seamlessly integrates into the daily lives of Switch 2 users.

Versatile Options for Every Scenario

The core innovation of the “Split EveryDay Case for Switch 2” lies in its modular, split-shell architecture. Built around an ultra-slim backplate, the case ensures the console can slide directly into the official charging dock without obstruction. From this foundation, players can choose between three distinct configurations:

  • Basic Version ($24.99): Includes the ultra-slim back shell and detachable grips. The grips now feature full soft-touch TPU coverage, enhancing durability while protecting the shoulder buttons from scratches.
  • Full Protection Version ($29.99): Adds a robust hard-shell front cover to the Basic kit. This shield offers complete impact resistance for the screen and Joy-Cons—ideal for active users needing extra security.
  • Travel Mode Version ($34.99): The flagship choice featuring a Flip-Style Magnetic Leather Cover. Functioning much like a premium tablet case, it offers elegant screen protection and instant access.

To ensure the best possible experience out of the box, JSAUX includes a complimentary foldable stand with every Split EveryDay Case, regardless of the version chosen.

Jsaux EveryDay Case for Switch 2
Jsaux EveryDay Case for Switch 2

Redefining On-the-Go Protection: The “Travel Mode” Experience

The Travel Mode edition introduces a refined way to carry the handheld.

  • Smart Protection: The magnetic cover securely shields the screen and Joy-Con joysticks from scratches inside a bag.
  • Instant Access: Simply flip it open to play. It transitions from commuting to gaming in seconds, offering a seamless experience.
  • Tabletop Mode: The cover doubles as a stand, allowing you to set up the console for hands-free gaming on flat surfaces.

Completing the Ecosystem: Rugged Utility vs. Lightweight Portability

This launch perfectly complements JSAUX’s existing lineup, offering a distinct choice alongside the award-winning ModCase (“Best of CES 2026” by GamesRadar+).

The ModCase for Switch 2 is built for ultimate security and versatility, offering robust 360° protection and a universal strap system across all kits, allowing players to attach power banks for extended gaming sessions.

The Split EveryDay Case for Switch 2 prioritizes seamless docking and daily convenience, tailored for commuters who value a slim profile and instant protection on the go.

Now, players can simply pick the protection that fits their lifestyle.

Coming Soon: The CES Crowd-Favorite “Joy-Con Energy Station for Switch”

Following its standout reception at CES 2026, JSAUX is also sharing an update on the highly anticipated Joy-Con Energy Station for Switch.

Praised for its unique aesthetic and utility on the show floor, this accessory ($21.99) delivers more than just power. It charges up to four Joy-Cons and one Pro Controller simultaneously, while also featuring 4K HDMI output for a complete docking experience.To ensure the best possible user experience, the team is taking additional time to fine-tune the final details. It is scheduled for release in late March or later.

ASSETS

Visual assets for JSAUX’s latest Switch 2 accessories can be found at this link.

CONTACT

For further information requests, feel free to contact us at marketing@jsaux.com. Also, you can reach out to a brand representative and follow the new product updates on social media!

ABOUT JSAUX

JSAUX, a pioneer brand in innovation and quality, boasts products that are best-sellers across over 100 countries and regions worldwide, serving more than 20 million consumers. Since 2016, multiple JSAUX product lines sold on Amazon have been designated as “#1 Best Sellers”, ranking first in several categories. This success has solidified JSAUX’s foothold in the electronics accessories market and has further established the brand as one of the top 100 Chinese brands on Amazon.

In 2022, JSAUX swiftly rose to become one of the most popular brands in gaming accessories, firmly establishing itself as the premier brand for Steam Deck accessories. The brand’s strong product innovation, superior quality, robust supply chain, and consumer-centric brand strategy have enabled it to continuously design and produce outstanding products over the past seven years. This accomplishment is the result of seamless coordination within our internal teams, spanning from research and development to product manufacturing and global marketing.

 

Bedsure Expands Offline Retail Footprint With Launch of Its GentleSoft® Ribbed Plush Blanket In Targets Nationwide

By
Advertorial Desk
-

The brand’s softest blanket is now available for shoppers to experience in person as Bedsure leans into offline growth 

NEW YORK, Jan. 29, 2026 /PRNewswire/ — Bedsure, a leading home textile brand trusted by millions worldwide, is expanding its in-store presence with its coziest addition yet: the Bedsure GentleSoft® Ribbed Plush Blanket, now available in Target stores nationwide allowing customers to touch, feel, and experience its signature comfort themselves.

Bedsure is now available at Target.
Bedsure is now available at Target.

Beloved by TikTok for its cloud-like softness, the Bedsure GentleSoft® Ribbed Plush Blanket has quickly become a fan favorite for its ability to elevate everyday comfort—bringing cozy luxury at an affordable price point. Now, with its rollout in Target stores across the country, customers can see firsthand why this blanket has earned a following.

Available in four stylish colorways—Linen, Light Grey, Crystal Pink, and Green—the blanket is designed to seamlessly complement any space. Whether draped over a couch, layered on a bed, or added to a reading nook, the Bedsure GentleSoft® Ribbed Plush Blanket provides instant comfort and an effortlessly cozy look. Each blanket is prewashed three times to protect its integrity, maintain its plush feel, and ensure it holds up through daily use, representing Bedsure’s belief in durability and long-term softness in all its products.

“At Bedsure, we believe that comfort is an essential wellness tool, and something that should be an accessible experience for everyone,” said Eric Lin, Chief Marketing Officer at Bedsure. “Partnering with Target gives us the opportunity to bring our signature softness and comfort offline and meet the consumers where they are.”

Bedsure’s expansion into offline channels through partnerships with Target and Belk, showcase Bedsure’s ongoing exploration and continued plans to expand into additional brick-and-mortar retail, working to bring essential comfort to even more households nationwide.

The Bedsure GentleSoft® Ribbed Plush Blanket is available in Twin/Twin XL ($30) and Full/Queen ($40) in Target retailers nationwide.

About Bedsure 

Founded in 2016, Bedsure is a leading home textile brand with products sold to over 40 million customers worldwide. Bedsure has over 50 bestselling home products in 8 countries and has maintained a compound growth rate of 100% for five consecutive years. While Bedsure has grown into a global company with a diverse range of products to meet various customer needs, its focus on providing comfortable home products and everyday value remains unchanged. For more information, visit Bedsure’s official website  https://bedsurehome.com/. Stay in touch with Bedsure on social media @bedsurehome. 

 

Cheche Group Announces Strategic Cooperation with Volkswagen DSSO and Cardif Airstar Insurance to Build Digital Insurance System with Intelligent Pricing Model

By
Advertorial Desk
-

BEIJING, Jan. 29, 2026 /PRNewswire/ — Cheche Group Inc. (NASDAQ: CCG) (“Cheche” or the “Company”), China’s leading auto insurance technology platform, today announced that Volkswagen (Anhui) Digital Sales and Services Co., Ltd. (“DSSO”), Beijing Cardif Airstar Property & Casualty Insurance Co., Ltd. (“Cardif Airstar Insurance”), and Cheche Group Inc. held a strategic cooperation signing ceremony on January 29, 2026. They will collaborate to develop digital insurance services for Volkswagen owners and expand into areas such as intelligent pricing, intelligent‑driving insurance, and non‑auto insurance. The partnership aims to establish a digital financial and insurance service system covering the full lifecycle of electric vehicle ownership.

DSSO is a wholly owned subsidiary of Volkswagen (China) Investment Co., Ltd. and a core enterprise within Volkswagen Group’s Intelligent Electric Vehicle Center in Hefei. Cardif Airstar Insurance is a Sino‑foreign joint venture property and casualty insurer, with BNP Paribas Cardif, Volkswagen Financial Services Overseas AG and Xiaomi Corporation as its shareholders. Cheche provides insurance services and digital platforms for DSSO.

Pursuant to the strategy, Volkswagen owners will access services through a unified digital entry point within the automaker’s app across electric vehicle purchase, usage, insurance, and financial service scenarios. Cardif Airstar Insurance will provide insurance product design and underwriting services, while Cheche will deliver one‑stop digital solutions through its embedded insurance SaaS system.

In the field of intelligent pricing, Cheche has established an industry-leading, full‑chain, dynamic data loop. The system integrates driving‑behavior data from intelligent connected vehicles—including rapid acceleration, hard braking, and steering‑angle indicators—together with road‑condition data, in‑vehicle interaction frequency, and industry claims data. This process generates a unique “risk profile” for each Volkswagen owner. With the support of AI‑based pricing and anti‑fraud models, these data points are transformed into precise pricing factors to achieve differentiated premiums under the principle of “better driving, better pricing.”

Cheche’s pricing model also features dynamic learning capabilities. By connecting to automaker’s electric power control systems with insurer direct repair program networks, real‑time claims data flows back into the model for parameter calibration, forming a positive cycle of “risk identification → pricing → claims → optimization.” As cooperation deepens, the partners will extend this intelligent pricing system into intelligent‑driving insurance, helping to address the challenge of liability determination in intelligent‑driving scenarios and to provide a practical reference for industry innovation.

“Today’s signing marks the beginning of a shared vision among all parties. By integrating data, technology, real‑world scenarios, and ecosystem resources, we will deliver a more seamless and intelligent service experience to Volkswagen owners. This cooperation enables us to jointly build solutions that support the full lifecycle of electric vehicle use and achieve meaningful improvements in service quality,” said Mr. Lei Zhang, founder and CEO of Cheche.

The three parties jointly witnessed the signing ceremony and committed to continue collaborating to serve Volkswagen owners, enabling users to benefit from comprehensive solutions built on data, technology, and collaborative ecosystems and experience meaningful improvements in service quality.

Safe Harbor Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements also include, but are not limited to, statements regarding existing and new partnerships and customer relationships, projections, estimation, and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, the Company’s advantages and expected growth, and its ability to source and retain talent, as applicable. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management, and are not predictions of actual performance. These statements involve risks, uncertainties, and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to materially differ from those expressed or implied by these forward-looking statements. Further information regarding these and other risks, uncertainties, or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. Although the Company believes that it has a reasonable basis for each forward-looking statement contained in this press release, the Company cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. The forward-looking statements in this press release represent the views of the Company as of the date of this press release. Subsequent events and developments may cause those views to change. Except as may be required by law, the Company does not undertake any duty to update these forward-looking statements.

About Cheche Group Inc.

Established in 2014 and headquartered in Beijing, China, Cheche is a leading auto insurance technology platform with a nationwide network of around 108 branches licensed to distribute insurance policies across 25 provinces, autonomous regions, and municipalities in China. Capitalizing on its leading position in auto insurance transaction services, Cheche has evolved into a comprehensive, data-driven technology platform that offers a full suite of services and products for digital insurance transactions and insurance SaaS solutions in China. Learn more at https://www.chechegroup.com/en.

Cheche Group Inc.:

IR@chechegroup.com

Crocker Coulson
crocker.coulson@aummedia.org
(646) 652-7185

Annual Pet Event “Pet Show 2026” Opens Today

By
Advertorial Desk
-

Nearly 1,000 Booths Gathered

Ancient Egypt and Mantis-Themed Zones Create a Pet-and-People Carnival

HONG KONG, Jan. 29, 2026 /PRNewswire/ — Organized by Exhibition Group, Hong Kong’s largest public pet exhibition, the “Pet Show 2026” (the Show), opens today through 1 February (Thursday to Sunday) at the Hong Kong Convention and Exhibition Centre. This year’s Show features nearly 1,000 booths, the most world-renowned pet food and supplies brands assembled in Hong Kong and is hailed as the “Brands and Products Expo” of the pet industry. Visitors can enjoy one-stop shopping for pet foods and drinks, apparel, toys, grooming and cleaning products, health supplements and medicines, cages and habitats, and more, meeting the needs of every beloved companion. Multiple themed zones and rich programming invite all pet lovers to attend with their pets and experience the festive atmosphere of the city’s signature annual pet event.

Annual Pet Event “Pet Show 2026” Opens Today.
Annual Pet Event “Pet Show 2026” Opens Today.

The opening ceremony was attended by Dr. Bernard Chan, Under Secretary for Commerce and Economic Development of the Government of the Hong Kong Special Administrative Region, Hon., Dr. Jackie Yip, Assistant Director (Inspection and Quarantine) of the Agriculture, Fisheries and Conservation Department, Mr. SHIU Ka-fai, Member of the CPPCC National Committee and Legislative Council, Ms. Helena Chen, Managing Director of Hong Kong & Macau, Mastercard Worldwide, Ms. Angela Chan, Chairman of Hong Kong Pet Trade Association, Dr. Louis Ng, Museum Director of the Hong Kong Palace Museum, Ms. Phebe Lo, Chairman of Hong Kong Black Cat Club, Mr. Rex Li, Honorary Chairman of Hong Kong Kennel Club, Mr. Kenneth Wong, Development Director of Life-Med Foundation Group Limited, Dr. Sharon Kwok, Ambassador for Endangered Species, and Mr. Carl Wong, Chairman of Exhibition Group.

Mr. Carl Wong, Chairman of Exhibition Group, said: “The global pet industry continues to grow, with the pet food market projected to reach US$134.46 billion in 2026. In Hong Kong, more than 240,000 households keep pets—over 400,000 animals in total—driving substantial related consumption. With the Government actively promoting pet-friendly policies and streamlining quarantine measures, the industry is embracing new opportunities. This year, the Pet Show is partnering for the first time with the Hong Kong Palace Museum to introduce an ‘Ancient Egypt Unveiled’ cultural experience zone, showcasing the profound bond between people and their pets. Looking ahead, we will continue to foster industry exchange and innovation, working together to build a more inclusive, pet-friendly city.”

“Ancient Egypt Unveiled” Special Zone: Giant “Pharaoh Cat” Debuts

For the first time, the Pet Show is collaborating with the Hong Kong Palace Museum to present a special zone themed after the “Ancient Egypt Unveiled: Treasures from Egyptian Museums” exhibition, featuring a 2.5-metre tall “Pharaoh Cat” installation—a must-visit photo spot this year. In ancient Egypt, cats were regarded as sacred animals and symbols of the household protector goddess Bastet. The zone will introduce artefacts related to the cat deity, enabling visitors to learn about the profound connection between ancient Egyptians and cats. Visitors who purchase tickets or memberships on-site will receive a complimentary “Pharaoh Cat” Lucky Charm*. A selection of the beloved ancient Egypt-themed merchandise will also be available, including the Black Cat Plush Collectible, the Pharaoh Pet Beanie, and the Hekha and Nekhakha Pet Teaser Set. Exclusive educational products, including the Ancient Egypt Unveiled: Young Explorer’s Guide picture book, Pyramid Paper Folding Kit, and the catalogue of the special exhibition “Ancient Egypt Unveiled: Treasures from Egypt Museums” will also be available*. Launching simultaneously on-site and across online platforms, the interactive activity “Searching for Pharaoh’s Cat” offers participants the chance to receive an exclusive, non-sale “Pharaoh Cat” Fan* on-site, allowing the public to discover ancient Egyptian culture while enjoying a new experience that blends pets with history.

*Limited quantities; while stocks last.

“Mantis Mania 2: Walking with the Dragons” Returns Multiple Themed Zones Become Photo Hotspots

The popular live mantis exhibition “Mantis Mania 2: Walking with the Dragons” returns with nearly 50 mantis species. This edition adds more than a dozen new species, including the colorful Metal Mantis, Peru’s largest clear‑winged giant mantis, the distinctive South American Rhombodera mantis, the East African Leopard Bullet mantis—resembling bullets and tree bark—and uniquely shaped A‑genus dead‑leaf mantises. To celebrate the upcoming Lunar New Year, the exhibition will feature the “Dragon Mantis,” whose form resembles the Chinese dragon, giving visitors a rare, up‑close look at these fascinating creatures.

This year’s Show also presents key themed zones and photo spots, including “Retro Goldfish Street” and “Mandy Cat Cha Chaan Teng x Mei Lok Store.” “Retro Goldfish Street” revisits Hong Kong’s classic pet culture, telling the history, evolution, and cultural significance of Goldfish Street, and showcases ornamental fish and related products, with knowledge‑sharing on aquatic plant cultivation, aquascaping, and sustainable fish breeding. Designed with retro neon signage and vibrant colors for an immersive experience, the zone also offers a goldfish ornament workshop to enhance interaction and participation. “Mandy Cat Cha Chaan Teng x Mei Lok Store” blends local cha chaan teng and nostalgic corner‑store elements with adorable cat motifs and vintage décor to create a warm, distinctly Hong Kong ambience—one of this year’s must‑visit photo spots.

Highlights and Diverse Pet Products for Every Family

During the Show, a rich lineup of programs will be staged, including a dog show organized by the Hong Kong Kennel Club, the “15th CFA Championship Cat Show” organized by the Hong Kong Black Cat Club, and the “19th Olympets.”

This year’s Pet Show also brings a diverse range of exhibitors catering to different household needs. Joywood Asia Limited (Booth: 1B R70) presents the Momoji series, which weaves Lunar New Year elements—wealth, prosperity, and good fortune—into pet accessories for a festive touch. Sketto Limited (Booth: 1D G38) features the Disney Zootopia series with cute, stylish designs perfect for matching looks with your pet. Baby Galleria HK (Booth: 1D F81) showcases Tavo pet safety capsules, WonderFold foldable strollers, and the Tavo Shell rocker, combining safety, comfort, and aesthetics for travel and home. Futex Corporation Limited (Booth: 1E C37) introduces the EBO Air 2 Plus home companion robot, offering smart monitoring and interactive entertainment to accompany pets and families around the clock. Pet Cubes (HK) Limited (Booth: 1B R08) launches “human‑grade” fresh pet meals inspired by Hong Kong cha chaan teng flavors, including Char Siu for dogs, as well as Singaporean classics such as braised duck rice—healthy and delicious for pets. Art Hunt Ceramic (Booth: 1C M73) invites visitors to craft ceramic art alongside their pets, creating keepsakes of warm shared moments.

Business Exchange to Drive Industry Growth

To recognize outstanding pet brands, the Show will host the “MoCity Favorite Pet Brand Awards 2025” ceremony, honoring brands beloved by the public and setting benchmarks for the industry. The fair also strengthens trade elements: in addition to exhibitors from Chinese Mainland, Korea, and China Taiwan, pet show organizers from Chinese Mainland, Singapore, Indonesia, Japan, and China Taiwan will co-promote the event to attract professional buyers for on-site exchange.

Ticketing and Spending Offers for Extra Fun

To double the excitement for visitors, purchasers of a ticket to either the “Hong Kong Holiday & Travel Expo 2026” or “Pet Show 2026” can buy one physical ticket to the other exhibition at a special price of HK$10 at the on-site ticket counter (regular price HK$30) by presenting the ticket stub—enjoy travel planning and pet fun in one trip. The on-site “Mastercard Scratch Card Lucky Draw” lets customers who spend every HK$500 in a single receipt at designated booths using a Mastercard receive one entry; HK$1,000 earns two entries, and so on, up to 10 entries per receipt. Prizes include round-trip air tickets for two to Tokyo, Seoul, and Taipei, with a total value over HK$150,000 and more than 3,000 prizes available. Participants can redeem scratch cards at the redemption counter for instant results. License numbers: 061009, 061010.

Pet Show 2026

Date

29 January – 1 February 2026 (Thursday to Sunday)

Time

29–31 January (Thu–Sat): 12:00 noon – 9:00 PM

1 February (Sun): 12:00 noon – 8:00 PM

Venue

Hall 1, Hong Kong Convention and Exhibition Centre

Website

https://www.exhibitiongroup.com.hk/exhibitions/petshow2026

 

About Exhibition Group

Exhibition Group Limited is one of Hong Kong’s renowned exhibition companies. Our core team has been assembled since 2003, bringing together a group of innovative, experienced, and professional exhibition talents. As a leading event management company, specializing in the planning and operation of world-class public exhibitions, conferences, and trade fairs, covering a wide range of industries. With years of industry experience, we are committed to the development of exhibition and marketing businesses, gaining a prestigious reputation within the exhibition industry.

Our company organizes a variety of themed exhibitions and marketing projects, which not only receive substantial support from the business community and exhibitors but also effectively attract a large number of public participants. Each event has garnered rave reviews, resulting in a win-win situation for exhibitors in both product promotion and sales. Notable exhibitions include the Pet Show, In-Home Expo, Premium Pet Supplies Expo, Hong Kong Cat Expo, Hong Kong Holiday & Travel Expo, Extracurricular Activities Festival cum Teaching Materials and Supplies Expo, and Hong Kong Outdoor & Sports Expo, among others. In recent years, our company has been honored with several awards, including the “Outstanding Award for Pandemic Resilience,” “ESG Commendation Awards,” and “Innovative Exhibition Planning,” recognizing our business development achievements across various sectors.

This press release is distributed by Market Hubs Holdings Limited.

For Media Enquiry,

Market Hubs Holdings Limited

Lierence Li

Debbie So

+852 3998-4900

+852 3998-4900

lierence@markethubsgroup.com

debbie@markethubsgroup.com

 

 

 

Innovate to Benefit Society: Clarivate validates PolyU’s research excellence–achieving outstanding growth in research output and global leadership in engineering and AI-medical research

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 29 January 2026 – The Hong Kong Polytechnic University (PolyU) yesterday unveiled the PolyU Research Excellence Report at a high-profile forum co-hosted with Clarivate, a leading global provider of transformative intelligence. The landmark report provides a comprehensive evaluation of PolyU research achievements and impact, reaffirming the University’s position as a global innovation powerhouse. The event, “Research Excellence Report Launch cum Impact Forum: Innovating for Global Impact”, drew around 100 distinguished attendees, including academic leaders from other tertiary institutions in Hong Kong and the Chinese Mainland, industry partners and policymakers. According to Clarivate, PolyU achieved a remarkable 65% surge in high-impact research output and a 55% rise in highly cited papers from 2020 to 2024, and led all University Grants Committee (UGC)-funded institutions in research publications in 2024, underscoring its position at the forefront of Hong Kong’s academic excellence.

The event was officiated by Prof. Timothy TONG, Chairman of the Research Grants Council (RGC); Mr Osher GILINSKY, Vice President for Asia Pacific, Academia and Government, Clarivate; and Prof. Christopher CHAO, Senior Vice President (Research and Innovation) of PolyU, who delivered opening remarks.

Celebrating PolyU’s exceptional research achievements and their far-reaching impacts on society, the Nation and the world, Prof. Tong stated, “The PolyU Research Excellence Report vividly demonstrates its commitment to sustainable development, reflecting the dedication and innovation of its faculty, researchers and students.” Prof. Tong commended PolyU for its effective use of research resources, noting the significant advancements in AI-driven medical breakthroughs, climate solutions and sustainability. He further emphasised the RGC’s ongoing commitment to supporting research that addresses major societal challenges, exemplified by initiatives such as the Research Impact Fund. Additionally, he reaffirmed the RGC’s partnership with universities in strengthening Hong Kong’s status as a global knowledge hub.

Recognising PolyU’s outstanding global research performance, Mr Gilinsky elaborated, “In recent years, PolyU has demonstrated high research productivity in high quality, driving for high impact for the society. PolyU was granted 1,020 patents between 2020 and 2024, the second highest among UGC-funded universities. To enhance research translation, PolyU has formed partnerships with companies including NVIDIA, Huawei and Alibaba. These achievements illustrate PolyU’s international connectivity, diverse disciplinary strengths and strong culture of research translation. Leveraging its strength with the Chinese Mainland resources, PolyU is also accelerating knowledge transfer and identifying emerging areas for discovery, particularly in AI-powered healthcare, sustainable engineering, advanced manufacturing and smart city development—fields where it aims for global leadership.”

Prof. Chao emphasised, “The report is a testament to years of dedicated effort, groundbreaking innovation and the unwavering commitment of the PolyU academic community. In 2025, we are proud to have 21 PolyU scholars named Highly Cited Researchers by Clarivate, while 428 rank among Stanford University’s World’s Top 2% Most-cited Scientists—placing PolyU second among Hong Kong tertiary institutions. Our Strategic Plan 2025/26 – 2030/31, themed ‘Unite to Meet Challenges, Innovate to Benefit Society,’ will further empower PolyU to deliver even more transformative contributions to society.”

Clarivate has been forging continuous collaborations with numerous institutions, including co-authoring the report series The impact of research undertaken by universities in Hong Kong with UGC in 2022. Produced by Clarivate using authoritative data from the Web of Science, the PolyU Research Excellence Report delivers a comprehensive assessment of the University’s overall research performance and achievements, highlighting PolyU’s global leadership in engineering, advancements in powering medical research with emerging AI technologies, and unique contributions to the hospitality, fashion and textile, design and art disciplines that distinguish the University on the global stage.

PolyU’s strengths are exemplified by its leadership in Hong Kong’s research output growth, achieving the highest number of publications among UGC‑funded universities in 2024. Nearly 40% of its outputs are internationally co-authored, while 27% involve QS Top 50 university partners. The quality and impact of the University’s research output are further evidenced by its strong disciplinary performance. In the QS World University Rankings by Subject 2025, seven PolyU disciplines rank in the global Top 30, while, overall, 26 disciplines are listed among the world’s Top 100, underscoring the breadth and depth of the University’s academic excellence across multiple fields.

Following the report launch, the Impact Forum featured a high-level panel discussion on “Innovations and Challenges in Research Evaluation”. The discussion facilitated insightful exchanges between the panel and attendees on evolving approaches to research assessment, the importance of measuring societal impact and strategies for fostering cross-institutional collaboration.

The PolyU Research Excellence Report is now available on the PolyU website: https://www.polyu.edu.hk/ipao/institutional-performance/research-excellence-report/

Highlights from the report:

  • Engineering Leadership: Ranked 6th globally in Engineering and 2nd in Civil Engineering (Subject Rankings of U.S. News & World Report Best Global Universities Rankings 2025-2026), with research supporting Hong Kong’s Cross Bay Link project and national space missions. PolyU engineering publications grew by 68% between 2020-2024, with 38% of Hong Kong’s engineering publications affiliated with the University in 2024.
  • AI-driven Medical Innovations: 261 patents in Computing and Control solutions, including LungRT Pro (a radiotherapy support system), Scolioscan® (radiation-free scoliosis diagnosis) and STARS (a smartphone-based vision screening tool for children). These life‑changing innovations demonstrate PolyU’s strong interdisciplinary integration across computer science, optometry, biomedical engineering, rehabilitation sciences and nursing.
  • Unique Disciplines: Global top rankings in Hospitality and Tourism Management, and Textile Science and Engineering (1st and 5th respectively in ShanghaiRanking’s Global Ranking of Academic Subjects 2025), as well as Art and Design (22nd in QS World University Rankings by Subject 2025). Groundbreaking work includes smart wearables for stroke patients, AI-powered tourism demand forecasting platforms and sustainable community design projects.
  • Collaborative Impact: Over 600 international collaboration agreements with 390+ institutions across 45 countries and regions, and 3,100+ collaborative projects in the Chinese Mainland. Between 2020 and 2024, nearly 40% of its high-quality research publications were co-authored with international institutions. PolyU Unicorn startups have created over 5,000 international job opportunities and generated significant economic value.

Hashtag: #PolyU #Clarivate #ResearchOutput #AIMedical #Engineering #HongKong

The issuer is solely responsible for the content of this announcement.

Saudi Arabia Unveils Ambitious New Privatization Strategy to Expand Public-Private Partnerships

By
Advertorial Desk
-
  • Strategy sets out 220+ new public-private partnerships contracts by 2030
  • Targets initial $64 billion (SAR 240 billion) in direct capex investment
  • Broadens private sector participation across new and existing projects
  • National Privatization Strategy accelerates realization of Saudi Vision 2030 economic diversification goals

RIYADH, Saudi Arabia, Jan. 29, 2026 /PRNewswire/ — The Kingdom of Saudi Arabia has launched a new National Privatization Strategy to significantly expand the role of public-private partnerships (PPPs) in delivering and operating large-scale projects and advancing economic diversification of in line with Saudi Vision 2030.

Led by the National Center for Privatization & PPP (NCP), the Strategy provides unprecedented opportunities for long-term foreign direct investment in initiatives to enhance the quality and efficiency of infrastructure and public services in the Kingdom, strengthen the role of the private sector in sustainable economic development, enable the government to focus on its legislative, regulatory and oversight roles, and enhance fiscal sustainability.

Saudi Minister of Finance and Chairman of the Board of the NCP, His Excellency Mr. Mohammed bin Abdullah Al-Jadaan, stated:
“In the Kingdom, we strive to establish future-ready infrastructure with high quality and efficiency, ensuring that public services delivered to citizens, residents, and visitors are among the best in the world, while strengthening the Kingdom’s position as a global reference in public-private partnerships.”

The National Privatization Strategy aims to increase resident and visitor satisfaction with public services across 18 targeted sectors, create tens of thousands of high-quality jobs, sign more than 220 PPP contracts by 2030, and mobilize over $64 billion (SAR 240 billion) in private capital investments by 2030.

The launch of the Strategy marks the transition from the foundational phase – successfully completed under the 2018 Privatization Program – to a new phase focused on execution and accelerating delivery. The Strategy will open up new sectors for private sector investment locally and internationally, including transport and logistics, water, health and education infrastructure and real estate, enable participation in larger and more complex projects, increase financing opportunities, as well as accelerate new partnerships and reinvestment in mature projects.

The government will seek partners for projects including the Saudi Landbridge linking east and west coasts through Riyadh, several education infrastructure projects, water desalination, treatment and strategic reservoir, as well as international airports.

The Strategy establishes five core programs related to planning, regulation, human capital, awareness and prioritization, to enable and advance the privatization ecosystem. These are supported by 42 executive initiatives to achieve its objectives and contribute to Vision 2030 privatization targets. It also includes an executive program dedicated to identifying and prioritizing privatization opportunities, with more than 145 priority opportunities identified—representing attractive investment prospects for the private sector.

The 2018 Privatization Program has achieved several key milestones, most notably the establishment of the National Center for Privatization & PPP (NCP), the approval of more than 200 projects with estimated total investments of approximately $213 billion, and the signing of nearly 90 contracts, including asset sale and PPP contracts across multiple sectors.

The Program also contributed to strengthening private sector participation, enhancing the operational efficiency of government assets, and advancing the legislative and regulatory environment that supports investment – thereby supporting economic diversification goals and improving the Kingdom’s competitiveness regionally and globally.

For more information contact: James Drewer, Ways, James@ways-sa.com

About the National Center for Privatization & PPP (NCP)

The National Center for Privatization & PPP (NCP) is the driving force behind Saudi Arabia’s Private Sector Participation (PSP) ecosystem. Established in 2017, NCP reports directly to the Council of Economic and Development Affairs and plays a vital role in developing world-class infrastructure and public services, contributing to the Kingdom’s sustainable development goals in line with Saudi Vision 2030.

NCP brings together public and private stakeholders, as well as government decision makers to unlock the full potential of the private sector to participate in privatization and public-private partnership (PPP) projects. This collaborative approach leverages private sector expertise and innovation to successfully deliver impactful PPP projects.

Find out more about the NCP here
https://www.ncp.gov.sa/en  and
https://www.ncp.gov.sa/en/NationalStrategy/Pages/default.aspx

About Vision 2030

Saudi Vision 2030, launched in 2016 by the Saudi Government under the leadership of HRH Crown Prince Mohammed bin Salman, is the Kingdom’s roadmap to modernize its society, economy, and government. It seeks to diversify the economy reducing dependence on oil exports and develop other industries including tourism, mining and finance.

The vision rests on three main pillars: positioning Saudi Arabia the “heart of the Arab and Islamic world”, becoming a global investment powerhouse, and transforming the country into a hub connecting Africa and Eurasia.

 

MicuRx Announces FDA Clearance of IND Application to Proceed to Phase 2a Trial of MRX-5 in Patients with Mycobacterium abscessus Pulmonary Disease

By
Advertorial Desk
-

FOSTER CITY, Calif., Jan. 29, 2026 /PRNewswire/ — MicuRx Pharmaceuticals, Inc. (“MicuRx”), a clinical-stage biopharmaceutical company focused on developing novel anti-infective therapies for drug-resistant bacterial infections, recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for MRX-5, enabling the company to initiate a Phase 2a clinical trial in patients with Mycobacterium abscessus pulmonary disease.

M. abscessus pulmonary disease is a serious and prevalent non-tuberculous mycobacterial (NTM) infection associated with high morbidity, prolonged treatment regimens, and limited effective therapeutic options. Current treatments often require multi-drug combinations over extended periods and are frequently complicated by poor tolerability and suboptimal outcomes.

MRX-5 is a novel oral antibacterial agent designed to target NTM. In preclinical studies, MRX-5 demonstrated potent activity against clinical isolates of M. abscessus, including strains resistant to existing standard-of-care therapies. The compound has also shown favorable pharmacokinetic and safety profiles in nonclinical and clinical studies.

“The FDA’s clearance of our IND for MRX-5 represents an important milestone for MicuRx and for patients suffering from M. abscessus pulmonary disease,” said President of MicuRx Jerry (Zhiyue) Li “This approval allows us to advance MRX-5 into a Phase 2a clinical trial,  which aim to assess its safety, and efficacy in patients with M. abscessus pulmonary disease.”

The Phase 2a trial is a multicenter study in the United States designed to evaluate MRX-5 in adults with confirmed M. abscessus pulmonary disease. The trial is expected to generate important clinical data to inform subsequent development  milestones.

This IND clearance further expands MicuRx’s clinical pipeline of anti-infective drugs, reinforcing the company’s commitment to addressing global challenges posed by antimicrobial resistance and difficult-to-treat bacterial infections.

About MRX-5

MRX-5 is a next-generation antibacterial agent being developed by MicuRx for the treatment of non-tuberculous mycobacterial infections, including M. abscessus. The compound is designed for oral administration and aims to provide a more effective and tolerable treatment option.

FDA granted orphan drug designation to MRX-5 for the treatment of NTM infections in 2024.

About MicuRx

MicuRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat serious and drug-resistant bacterial infections. Leveraging deep expertise in medicinal chemistry and anti-infective drug development, MicuRx aims to deliver differentiated therapies to address significant unmet medical needs worldwide.

 

1...1,1721,1731,174...6,487Page 1,173 of 6,487